Top in ID: SARS-CoV-2 levels in wastewater, a look back on the early days of the pandemic
Click Here to Manage Email Alerts
Data from the CDC revealed an increase in SARS-CoV-2 levels among 165 wastewater surveillance sites in the United States.
A CDC spokesperson said it is too early to tell whether the trend will continue or if there will be a corresponding increase in cases. It was the top story in infectious disease last week.
Another top story was the first installment of Healio’s new “Life during COVID” series, in which experts discuss topics such as how the COVID-19 pandemic has reshaped American medicine and society. In the article, physicians shared their memories of the first few months of the pandemic, from the initial reports of an outbreak in Wuhan to the first stay-at-home order in the United States.
Read these and more top stories in infectious disease below:
CDC: ‘Uptick’ in wastewater sites reporting increase in SARS-CoV-2 levels
The CDC’s wastewater surveillance tracker shows that 165 U.S. sites have experienced an increase in SARS-CoV-2 levels in the last 15 days. Read more.
‘This is gonna be bad’: An oral history of the early days of COVID-19
What started as an outbreak of viral pneumonia that infected dozens of people in a city in central China has grown into a pandemic that has killed nearly one million people in the United States alone. Read more.
Pfizer-BioNTech seek EUA for fourth dose of COVID-19 vaccine for older adults
Pfizer and BioNTech announced this week that they are seeking an emergency use authorization from the FDA for an additional booster dose of their COVID-19 vaccine for older adults. Read more.
New clinical trial will test three mRNA vaccine candidates for HIV
The National Institute of Allergy and Infectious Diseases announced that it has initiated a phase 1 clinical trial of three experimental messenger RNA HIV vaccines. Read more.
CDC-funded program combines ID fellowship with 2-year EIS rotation
A new CDC-funded program will combine an infectious diseases fellowship with a stint in the agency’s Epidemic Intelligence Service, the Infectious Diseases Society of America announced. Read more.